Antiplatelet therapy as an element of primary and secondary prevention of ischemic stroke
Antiplatelet medications are essential in the primary and secondary prevention of stroke. All currently available antiplatelet drugs are platelet aggregation inhibitors acting at various points of application, but they differ in their mechanism of action. Successful treatment and prevention of cereb...
Main Authors: | E. Y. Solovyova, E. D. Dzhutova, E. A. Tyutyumova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2016-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1301 |
Similar Items
-
Endothelial dysfunction and hemostasis in acute myocardial infarction before and after Trombovazim therapy
by: Ye. F. Kotovshchikova, et al.
Published: (2011-02-01) -
Disfunktsiya endoteliya i narusheniya trombotsitarno-koagulyatsionnogo gemostaza v razvitii diabeticheskoy nefropatii pri sakharnom diabete 2 tipa
by: V I Sizikov, et al.
Published: (2007-03-01) -
Antiplatelet therapy in secondary prevention of ischemic stroke
by: V. A. Parfyonov, et al.
Published: (2015-12-01) -
Influence of different methods of anesthesia on hemostasis systemin proctological patients
by: S. M. Dadeko, et al.
Published: (2008-06-01) -
Comparative effectiveness of antiplatelet therapy of hemostatic disorders in diabetes of the second type
by: S. A. Pavlishcuk, et al.
Published: (2015-08-01)